Cytochrome P450 1A1 genetic polymorphisms and risk of hepatocellular carcinoma among chronic hepatitis B carriers

British Journal of Cancer

Volumn 80, Issue 3-4, 1999, Pages 598-603

  Yu, M W ^a   Chiu, Y H ^a   Yang, S Y ^a   Santella, RmM ^b   Chern, H D ^c   Liaw, Y F ^d   Chen, C J ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b New York Presbyterian Morgan Stanley Children's Hospital   (United States)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Chronic hepatitis B virus carriers; Cigarette smoking; Cytochrome P450 1A1; Glutathione S transferase M1; Hepatocellular carcinoma; Nested case control study

Indexed keywords

CIGARETTE SMOKE; CYTOCHROME P450 ISOENZYME; GLUTATHIONE TRANSFERASE; POLYCYCLIC AROMATIC HYDROCARBON;

ADULT; ARTICLE; CANCER RISK; CHRONIC HEPATITIS; CIGARETTE SMOKING; CONTROLLED STUDY; DETOXIFICATION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HEPATITIS B; HUMAN; HUMAN TISSUE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SMOKING; VIRUS CARRIER;

EID: 0032927750     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690397     Document Type: Article

References (33)

1. Agundez JAG, Olivera M, Ladero JM, Rodriguez-Lescure A, Ledesma MC, Diaz-Rubio M, Meyer UA and Benitez J (1996) Increased risk for hepatocellular carcinoma in NAT2-slow acetylators and CYP2D6-rapid metabolizers. Pharmacogenetics 6: 501-512
2. Beasley RP (1988) Hepatitis B virus: the major etiology of hepatocellular carcinoma. Cancer 61: 1942-1956
3. Chen CJ, Liang KY, Chang AS, Chang YC, Lu SN, Liaw YF, Chang WY, Sheen MC and Lin TM (1991) Effects of hepatitis B virus, alcohol drinking, cigarette smoking and familial tendency on hepatocellular carcinoma. Hepatology 13: 398-406
4. Chen CJ, Yu MW, Liaw YF, Wang LW, Chiamprasert S, Matin F, Hirvonen A, Bell DA and Santella RM (1996) Chronic hepatitis B carriers with null genotypes of glutathione S-transferase M1 and T1 polymorphisms who are exposed to aflatoxin are at increased risk of hepatocellular carcinoma. Am J Hum Genet 59: 128-134
5. Crofts F, Taioli E, Trachman J, Cosma GN, Currie D, Toniolo P and Garte SJ (1994) Functional significance of different human CYP1A1 genotypes. Carcinogenesis 15: 2961-2963
6. 1. Cancer Res 54: 101-108
7. Guengerich FP (1991) Interindividual variation in biotransformation of carcinogens: basis and relevance. In Molecular Dosimetry and Human Cancer: Analytical, Epidemiological, and Social Considerations, Groopman JD and Skipper PL (eds), pp. 27-51. CRC Press: Boston
8. Guengerich FP and Shimada T (1991) Oxidation of toxic and carcinogenic chemicals by human cytochrome P450 enzymes. Chem Res Toxicol 4: 391-407
9. Hein DW, Doll MA, Rustan TD, Gray K, Feng Y, Ferguson RJ and Grant DM (1993) Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases. Carcinogenesis 14: 1633-1638
10. International Agency for Research on Cancer (1986) IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Vol 38, Tobacco Smoking. IARC: Lyon
11. Kawajiri K, Nakachi K, Imai K, Watanabe J and Hayashi S (1993) The CYP1A1 gene and cancer susceptibility. Crit Rev Oncol Hematol 14: 77-87
12. Mannervik B and Danielson UH (1988) Glutathione transferase: structure and catalytic activity. Crit Rev Biochem Mol Biol 23: 281-337
13. McKinnon RA, Hall PM, Quattrochi LC, Tukey RH and McManus ME (1991) Localization of CYP1A1 and CYP1A2 messenger RNA in normal human liver and in hepatocellular carcinoma by in situ hybridization. Hepatology 14: 848-856
14. Muscat JE, Richie JP, Jr, Thompson S and Wynder EL (1996) Gender differences in smoking and risk for oral cancer. Cancer Res 56: 5192-5197
15. Nakachi K, Imai K, Hayashi S and Kawajiri K (1993) Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population. Cancer Res 53: 2994-2999
16. Oyama T, Mitsudomi T, Kawamoto T, Ogami A, Osaki T, Kodama Y and Yasumoto K (1995) Detection of CYP1A1 gene polymorphism using designed RFLP and distributions of CYP1A1 genotypes in Japanese. In Arch Occup Environ Health 67: 253-256
17. Petersen DD, McKinney CE, Lkeya K, Smith HH, Bale AE, McBride OW and Nebert DW (1991) Human CYP1A1 gene: cosegregation of the enzyme inducibility phenotype and an RFLP. Am J Hum Genet 48: 720-725
18. Rebbeck TR (1997) Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarkers Prev 6: 733-743
19. Schweikl H, Taylor JA, Kitareewan S, Linko P, Nagorney D and Goldstein JA (1993) Expression of CYP1A1 and CYP1A2 genes in human liver. Pharmacogenetics 3: 239-249
20. Shen FM, Lee MK, Gong HM, Cai XQ and King MC (1991) Complex segregation analysis of primary hepatocellular carcinoma in Chinese families: interaction of inherited susceptibility and hepatitis B viral infection. Am J Hum Genet 49: 88-93
21. Shimada T, Yun CH, Yamazaki H, Gautier JC, Beaune PH and Guengerich FP (1992) Characterization of human lung microsomal cytochrome P450 1A1 and its role in oxidation of chemical carcinogens. Mol Pharmacol 41: 856-864
22. Sivaraman L, Leatham MP, Yee J, Wilkens LR, Lau AF and Marchand LL (1994) CYP1A1 genetic polymorphisms and in situ colorectal cancer. Cancer Res 54: 3692-3695
23. Spitz MR, Fueger JJ, Beddingfield NA, Annegers JF, Hsu TC and Newell GR (1989) Chromosome sensitivity to bleomycin-induced mutagenesis, an independent risk factor for upper aerodigestive tract cancers. Cancer Res 49: 4626-4628
24. Talaska G, Al-Juburi AZSS and Kadlubar FF (1991) Smoking related carcinogen-DNA adducts in biopsy samples of human urinary bladder: identification of N-(deoxyguanosin-8-yl)-4-aminobiphenyl as a major adduct. Proc Natl Acad Sci USA 88: 5350-5354
25. Tiollais P, Pourcel C and Dejean A (1985) The hepatitis B virus. Nature 317: 489-495
26. Tsukuma H, Hiyama T, Oshima A, Sobue T, Fujimoto I, Kasugai H, Kojima J, Sasaki Y, Imaoka S, Horiuchi N and Okuda S (1990) A case-control study of hepatocellular carcinoma in Osaka, Japan. Int J Cancer 45: 231-236
27. Wynder EL and Hoffmann D (1994) Smoking and lung cancer: scientific challenges and opportunities. Cancer Res 54: 5284-5295
28. Yu MC, Tong MJ, Govindarajan S and Henderson BE (1991) Nonviral risk factors for hepatocellular carcinoma in a low-risk population, the Non-Asians of Los Angeles County, California. J Natl Cancer Inst 83: 1820-1826
29. Yu MW, You SL, Chang AS, Lu SN, Liaw YF and Chen CJ (1991) Association between hepatitis C virus antibodies and hepatocellular carcinoma in Taiwan. Cancer Res 51: 5621-5625
30. Yu MW and Chen CJ (1994) Hepatitis B and C viruses in the development of hepatocellular carcinoma. Crit Rev Oncol Hematol 17: 71-91
31. Yu MW, Gladek-Yarborough A, Chiamprasert S, Santella RM, Liaw YF and Chen CJ (1995a) Cytochrome P450 2E1 and glutathione S-transferase M1 polymorphisms and susceptibility to hepatocellular carcinoma. Gastroenterology 109: 1266-1273
32. Yu MW, Hsieh HH, Pan WH, Yang CS and Chen CJ (1995b) Vegetable consumption, serum retinol level, and risk of hepatocellular carcinoma. Cancer Res 55: 1301-1305
33. Yu MW, Lien JP, Santella RM, Liaw YF and Chen CJ (1997) Effect of aflatoxin metabolism and DNA adduct formation on hepatocellular carcinoma among chronic hepatitis B carriers in Taiwan. J Hepatol 27: 320-330